Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, signed off Sunday on Johnson & Johnson’s one-shot Covid-19 vaccine for those 18 years of age and older as the federal government prepares to ship out millions of doses this week.
Walensky’s green light comes after an advisory panel to the CDC voted unanimously to recommend the use of Johnson & Johnson’s vaccine….
The J&J vaccine will be third Covid-19 vaccine to be distributed across the United States….
It is not as effective as the Pfizer or Moderna vaccine’s, against Covid but it’s advantage is it’s a one shot application…None of the tested people got severely sick….
The review, although positive, was more nuanced than regulators’ assessments of the first two coronavirus vaccines, reflecting a pandemic that has entered a more complicated phase as variants capable of slipping by some aspects of immunity have emerged. The Johnson & Johnson vaccine was 85 percent effective at preventing severe illness, including in a region dominated by a concerning variant, but only 66 percent protective overall when moderate cases were included….
The review found vaccine efficacy against severe covid-19 “was similarly high across the United States, South Africa, and Brazil.”
“We know this vaccine prevents 85 percent of the severe disease … It was 100 percent effective in preventing hospitalization and deaths, and that’s really what’s important,” said Nancy M. Bennett, a professor of medicine and public health sciences at the University of Rochester School of Medicine and Dentistry. “Those facts are the most important thing to recognize”….